These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Clinical significance of prognostic inflammation-based and/or nutritional markers in patients with stage III gastric cancer. Toyokawa T, Muguruma K, Yoshii M, Tamura T, Sakurai K, Kubo N, Tanaka H, Lee S, Yashiro M, Ohira M. BMC Cancer; 2020 Jun 03; 20(1):517. PubMed ID: 32493247 [Abstract] [Full Text] [Related]
7. Neutrophil count and the inflammation-based glasgow prognostic score predict survival in patients with advanced gastric cancer receiving first-line chemotherapy. Li QQ, Lu ZH, Yang L, Lu M, Zhang XT, Li J, Zhou J, Wang XC, Gong JF, Gao J, Li J, Li Y, Shen L. Asian Pac J Cancer Prev; 2014 Jun 03; 15(2):945-50. PubMed ID: 24568523 [Abstract] [Full Text] [Related]
10. Pretreatment C-reactive protein/albumin ratio is associated with poor survival in patients with stage IB-IIA cervical cancer. Zhang W, Liu K, Ye B, Liang W, Ren Y. Cancer Med; 2018 Jan 03; 7(1):105-113. PubMed ID: 29193777 [Abstract] [Full Text] [Related]